Abstract
The Importance of Addressing Multiple Risk Markers in Type 2 Diabetes: Results from the LEADER Trial
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have